보로노이
118,800KRWMarket close of 10/27 (Tue)
Down -2.86%-3,500KRWMarket close of 10/27 (Tue)
Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)121,100KRWUp +1.94%
Preliminary · replaced once official KRX data for the same date is published
- Open
- 124,700
- High
- 127,000
- Low
- 115,900
- Day range
- Day range low 115,900 high 127,000, open 124,700, close 118,800, previous close 122,300
- Volume
- 7×10K shares
- 8.9B KRW 0.96× the 20-session average
Market close of 10/27 (Tue)
Where it sits in the 1-year range
7%1-year close range 100,800 to 363,500 won, 7% up from the low
7% of the way up from the lowest close in 1 year (252 sessions) · -67.3% from the high
Loading
Free · no sign-inSource from 2021-05-17
Data dateMost recent closing data10/27 (Tue)
Market close data of 2026-10-27Points to check
- Earningsto check-81.0B KRWOperating income over the last four quarters -81.0B KRW (loss)
- Foreign & institutionalto check-1.9B KRW5 sessions: foreign -0.6B KRW · institutional -1.3B KRWLast 5 sessions: foreigners -600.00 million KRW · institutions -1.3B KRW
- Recent filingsnot verifiedCould not read filing data, so not verified
The other 2 are within the usual range
- Daily move-2.86%usual range
- Trading value1.0×usual range
See the full check report
Same sector · 바이오 R&D
Down -0.67%· 26 of 64 stocks up, preferred shares excluded · trading value 190.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -12.6% | Flat 0.00% | 51.8B KRW |
| 올릭스 | Close over the last 20 sessions -11.8% | Down -5.72% | 24.1B KRW |
| 디앤디파마텍 | Close over the last 20 sessions -8.3% | Up +0.37% | 14.0B KRW |
| 리가켐바이오 | Close over the last 20 sessions -20.9% | Down -1.54% | 12.1B KRW |
| 페니트리움바이오 | Close over the last 20 sessions -4.2% | Up +14.41% | 9.8B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 19 days
- Next data 10/29 (Thu) after 08:50
Related news
Loading
Tables, financials, investor flows and filing history are in the Detailed view.
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.